An individual research topic involving nonclinical studies and joint research and development of an autologous dendritic cell vaccine pulsed with SARS-CoV-2 antigen, conducted with the National Cancer Center and Keio University. The research aimed at preventing COVID-19 has ended, and development was discontinued.